bioMason Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 36
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 4

bioMason General Information

Description

Developer of a biotechnology based building materials technology designed to offer biological cement-based building materials. The company's biotechnology based building materials technology uses natural microorganisms and chemical processes and develops masonry materials at room temperature that replaces traditional clay and concrete without the high energy consumption associated with standard manufacturing, enabling builders to get cement and other building materials.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Building Products
Other Industries
Other Materials
Primary Office
  • 2 Davis Drive
  • Box 152, Research Triangle Park
  • Durham, NC 27709
  • United States

bioMason Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

bioMason Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Debt - PPP 09-Apr-2020 00.00 Completed
9. Later Stage VC 09-Dec-2019 00.000 00.00 Completed Generating Revenue
8. Debt - General 04-Mar-2016 00000 00.000 Completed Startup
7. Angel (individual) 22-Dec-2015 00.00 00000 Completed Startup
6. Grant 01-Sep-2015 00000 00000 Completed Startup
5. Debt - General 13-May-2014 00000 00000 Completed Startup
4. Grant 01-Jan-2014 00000 00000 Completed Startup
3. Grant 16-Sep-2013 00000 00000 Completed Startup
2. Early Stage VC 09-Sep-2013 $520K $570K Completed Startup
1. Debt - General 20-May-2013 $50K $50K Completed Startup
To view bioMason’s complete valuation and funding history, request access »

bioMason Executive Team (3)

Name Title Board Seat Contact Info
Ginger Dosier Co-Founder, Board Member & Chief Executive Officer
Michael Dosier Co-Founder, Chief Technology Officer & Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

bioMason Board Members (2)

Name Representing Role Since
Edison Hudson bioMason Board Member 000 0000
Michael Noël Self Board Member 000 0000
To view bioMason’s complete board members history, request access »

bioMason Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

bioMason Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Novo Holdings Venture Capital Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
Postcode Lottery Green Challenge Not-For-Profit Venture Capital 000 0000 000000 0
Acorn Innovestments Venture Capital Minority 000 0000 000000 0
To view bioMason’s complete investors history, request access »